Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Highly Emetogenic Chemotherapy”

74 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 74 results

Large-scale testing (Phase 3)Study completedNCT02116530
What this trial is testing

Antiemetic Therapy With or Without Olanzapine in Preventing Chemotherapy-Induced Nausea and Vomiting in Patients With Cancer Receiving Highly Emetogenic Chemotherapy

Who this might be right for
Hematopoietic/Lymphoid CancerNausea and VomitingUnspecified Adult Solid Tumor, Protocol Specific
Alliance for Clinical Trials in Oncology 401
Not applicableStudy completedNCT01366599
What this trial is testing

CV Events in Emetogenic Chemotherapy

Who this might be right for
VomitingCardiovascular EventArterial Thromboembolic Event
GlaxoSmithKline 12,058
Large-scale testing (Phase 3)UnknownNCT01536691
What this trial is testing

Ramosetron, Aprepitant and Dexamethasone Versus Ondansetron, Aprepitant and Dexamethasone

Who this might be right for
CancerMalignancy
Hallym University Medical Center 338
Not applicableStudy completedNCT01346267
What this trial is testing

Acupressure in Controlling Nausea in Young Patients Receiving Highly Emetogenic Chemotherapy

Who this might be right for
Central Nervous System Tumor, PediatricChemotherapy-induced Nausea and VomitingUnspecified Childhood Solid Tumor, Protocol Specific
University of South Florida 187
Early research (Phase 1)Not Yet RecruitingNCT07130617
What this trial is testing

Evaluation of the Efficacy and Safety of Megestrol Acetate in Preventing Nausea and Vomiting Induced by Highly Emetogenic Chemotherapy

Who this might be right for
EfficacySafetyMegestrol Acetate+1 more
Changchun GeneScience Pharmaceutical Co., Ltd. 132
Large-scale testing (Phase 3)Study completedNCT00343460
What this trial is testing

APF530 or Aloxi (Palonosetron Hydrochloride) Combined With Dexamethasone in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy for Cancer

Who this might be right for
Nausea and VomitingUnspecified Adult Solid Tumor, Protocol Specific
Heron Therapeutics 1,428
Large-scale testing (Phase 3)Study completedNCT00880191
What this trial is testing

Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy

Who this might be right for
Nausea and VomitingUnspecified Adult Solid Tumor, Protocol Specific
Alliance for Clinical Trials in Oncology 430
Large-scale testing (Phase 3)Study completedNCT00431236
What this trial is testing

The Drug Casopitant for the Prevention of Nausea Caused By Cisplatin-Based Highly Emetogenic Chemotherapy

Who this might be right for
Nausea and Vomiting, Chemotherapy-Induced
GlaxoSmithKline 810
Post-approval studies (Phase 4)Looking for participantsNCT07482891
What this trial is testing

An Exploratory Study on Efficacy and Safety of Fosaprepitant and Palonosetron Hydrochloride for Injection in Preventing CINV From Multi-Agent HEC

Who this might be right for
Chemotherapy-induced Nausea and Vomiting
Shanghai 6th People's Hospital 200
Large-scale testing (Phase 3)UnknownNCT05346731
What this trial is testing

Low Dose Olanzapine to the Prophylaxis of Nausea and Vomiting Induced by Chemotherapy in Children and Adolescents

Who this might be right for
Chemotherapy-induced Nausea and Vomiting
Federal Research Institute of Pediatric Hematology, Oncology and Immunology 210
Large-scale testing (Phase 3)Study completedNCT03578081
What this trial is testing

Olanzapine With or Without Fosaprepitant Dimeglumine in Preventing Chemotherapy Induced Nausea and Vomiting in Cancer Patients Receiving Highly Emetogenic Chemotherapy

Who this might be right for
Malignant Neoplasm
Alliance for Clinical Trials in Oncology 690
Testing effectiveness (Phase 2)Study completedNCT00169572
What this trial is testing

Study for The Prevention Of Nausea in Cancer Patients Receiving Highly Emetogenic Cisplatin Based Chemotherapy

Who this might be right for
Nausea and VomitingChemotherapy-Induced
GlaxoSmithKline 492
Testing effectiveness (Phase 2)Study completedNCT04669132
What this trial is testing

Efficacy of Olanzapine, Netupitant and Palonosetron in Controlling Nausea and Vomiting Associated With Highly Emetogenic Chemotherapy in Patients With Breast Cancer

Who this might be right for
Nausea Post Chemotherapy
Instituto Brasileiro de Controle do Cancer 50
Post-approval studies (Phase 4)Study completedNCT00684463
What this trial is testing

Palonosetron in Moderately and Highly Emetogenic Chemotherapy Induced Nausea and Vomiting (Study P04935)(COMPLETED)

Who this might be right for
NeoplasmsNauseaVomiting
Merck Sharp & Dohme LLC 59
Large-scale testing (Phase 3)Study completedNCT02517021
What this trial is testing

A Safety Study of Intravenous Pro-Netupitant and Palonosetron Combination for the Prevention of Nausea and Vomiting

Who this might be right for
Chemotherapy-Induced Nausea and Vomiting
Helsinn Healthcare SA 405
Large-scale testing (Phase 3)UnknownNCT04536558
What this trial is testing

Olanzapine Plus Fosaprepitant Standard Antiemetic Therapy in the Prevention of Chemotherapy-induced Nausea and Vomiting in Patients Receiving High Emetic Risk Multi-day Chemotherapy: a Multicenter, Randomized, Double-blind, Placebo-controlled, Phase 3 Study

Who this might be right for
Solid Tumor Patients Receiving High Emetic Risk Multi-day Chemotherapy
Sun Yat-sen University 352
Large-scale testing (Phase 3)Study completedNCT01661335
What this trial is testing

Efficacy of Aprepitant (Emend®) in Children

Who this might be right for
NauseaVomitingChildhood Cancer
University of Oklahoma 19
Testing effectiveness (Phase 2)Study completedNCT00787566
What this trial is testing

Phase 2 Study of Efficacy, Tolerability, and Safety of Intranasal Granisetron for Chemo-Induced Nausea and Vomiting

Who this might be right for
Chemotherapy-Induced Nausea and Vomiting
Shin Nippon Biomedical Laboratories, Ltd. 68
Post-approval studies (Phase 4)Study completedNCT01481831
What this trial is testing

Efficacy and Safety of Palonosetron Hydrochloride in the Prevention of Nausea and Vomiting

Who this might be right for
NeoplasmsChemotherapy-Induced Nausea and Vomiting
Shanghai Changzheng Hospital 599
Large-scale testing (Phase 3)Study completedNCT01937156
What this trial is testing

Controlled Trial of SP-01 (Granisetron Transdermal Delivery System) in Chemotherapy-induced Nausea and Vomiting

Who this might be right for
Chemotherapy-induced Nausea and Vomiting
Solasia Pharma K.K. 313
Next Page